Logo image of HYPRO.OL

HYDROGENPRO ASA (HYPRO.OL) Stock Earnings & Estimates

Europe - Euronext Oslo - OSL:HYPRO - NO0010892359 - Common Stock

2.095 NOK
0 (-0.24%)
Last: 12/23/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
HYPRO.OL revenue by date.HYPRO.OL revenue by date.
56.414M
181.56%
568.233M
907.26%
195.688M
-65.56%
92.7M
-52.63%
213.21M
130.00%
413.03M
93.72%
N/AN/AN/A
EBITDA
YoY % growth
HYPRO.OL ebitda by date.HYPRO.OL ebitda by date.
-105.252M
-90.52%
-36.011M
65.79%
-204.184M
-467.00%
167.89M
182.22%
126.69M
-24.54%
82.4M
-34.96%
1.275B
1,447.33%
1.593B
24.94%
1.969B
23.60%
EBIT
YoY % growth
HYPRO.OL ebit by date.HYPRO.OL ebit by date.
-119.242M
-97.22%
-58.292M
51.11%
-227.449M
-290.19%
-190.55M
16.22%
-151.41M
20.54%
-106.09M
29.93%
N/AN/AN/A
Operating Margin
HYPRO.OL operating margin by date.HYPRO.OL operating margin by date.
-211.37%-10.26%-116.23%-205.56%-71.01%-25.69%N/AN/AN/A
EPS
YoY % growth
HYPRO.OL eps by date.HYPRO.OL eps by date.
-1.52
-73.86%
N/A
30.32%
-2.89
-172.54%
-2.67
7.69%
-1.78
33.20%
-1.25
30.06%
N/AN/AN/A

All data in NOK

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in NOK

Recent Earnings VS Estimates Surprises (NOK)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-0.54
-315.38%
-0.570.035.15%
Q3 2024
Q2Q % growth
-0.59
-13.46%
-0.34-0.25-74.81%
Q2 2024
Q2Q % growth
-1.14
-1,136.36%
-0.56-0.58-102.66%
Q1 2024
Q2Q % growth
-0.62 -0.650.034.68%
Q4 2023
Q2Q % growth
-0.13
67.33%
-0.650.5279.95%
Q3 2023
Q2Q % growth
-0.52
-37.57%
-0.23-0.29-126.28%
Q2 2023
Q2Q % growth
0.11
130.72%
-0.110.22201.44%
Q4 2022
Q2Q % growth
-0.40
-37.93%
-0.410.012.63%
Q3 2022
Q2Q % growth
-0.38
-90.00%
-0.27-0.10-37.83%
Q2 2022
Q2Q % growth
-0.36
-56.52%
-0.29-0.06-22.15%
Q1 2022
Q2Q % growth
-0.39
-143.75%
-0.27-0.11-41.46%
Q4 2021
Q2Q % growth
-0.29
-383.34%
-0.27-0.02-7.72%
Q3 2021
Q2Q % growth
-0.20 -0.270.0725.71%
Q2 2021
Q2Q % growth
-0.23 -0.340.1133.42%
Q1 2021
Q2Q % growth
-0.16 0.04-0.20-488.33%
Q4 2020
Q2Q % growth
-0.06 -0.100.0438.69%
HYPRO.OL Yearly EPS VS EstimatesHYPRO.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5 -2 -2.5
Recent Revenue VS Estimates Surprises (NOK)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
12.382M
-75.19%
%
Q1 2025
Q2Q % growth
22.396M
446.78%
%
Q4 2024
Q2Q % growth
70.053M
-44.97%
91.091M-21.038M-23.10%
Q3 2024
Q2Q % growth
71.635M
-67.51%
157.5M-85.865M-54.52%
Q2 2024
Q2Q % growth
49.904M
-63.58%
56.251M-6.347M-11.28%
Q1 2024
Q2Q % growth
4.096M
-95.09%
11.321M-7.225M-63.82%
Q4 2023
Q2Q % growth
127.308M
403.57%
69.087M58.221M84.27%
Q3 2023
Q2Q % growth
220.461M
1,412.91%
124.93M95.531M76.47%
Q2 2023
Q2Q % growth
137.039M
1,662.56%
154.06M-17.021M-11.05%
Q1 2023
Q2Q % growth
83.425M
849.41%
%
Q4 2022
Q2Q % growth
25.281M
128.48%
41.083M-15.802M-38.46%
Q3 2022
Q2Q % growth
14.572M
76.87%
30.002M-15.43M-51.43%
Q2 2022
Q2Q % growth
7.775M
5,745.86%
39.065M-31.29M-80.10%
Q1 2022
Q2Q % growth
8.787M
1,369.40%
27.57M-18.783M-68.13%
Q4 2021
Q2Q % growth
11.065M
-28.42%
9.165M1.9M20.73%
Q3 2021
Q2Q % growth
8.239M
85.90%
9.165M-926K-10.10%
Q2 2021
Q2Q % growth
133K 8.637M-8.504M-98.46%
Q1 2021
Q2Q % growth
598K 26.78M-26.182M-97.77%
Q4 2020
Q2Q % growth
15.459M 6.48M8.979M138.56%
HYPRO.OL Yearly Revenue VS EstimatesHYPRO.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%